Study of LW402 Tablets in Moderate to Severe Rheumatoid Arthritis
Clinical trial NCT06800157 · COMPLETED
Trial details
- NCT number
- NCT06800157
- Sponsor
- Shanghai Longwood Biopharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-27
- Primary completion
- 2024-05-26
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.